Question 1

Does Cresset Asset Management own MCRB stock?

Accepted Answer

No. Cresset Asset Management exited its MCRB (Seres Therapeutics) position in Q3 2021. Its Q2 2021 13F listed 20,243 shares worth $483,000.

Question 2

How many shares of MCRB does Cresset Asset Management own?

Accepted Answer

None since Q3 2021, when Cresset Asset Management exited the position. Its Q2 2021 13F listed 20,243 shares worth $483,000.

Question 3

What is Cresset Asset Management's MCRB position worth?

Accepted Answer

Cresset Asset Management's MCRB position was worth $483,000 in its Q2 2021 13F, before the exit in Q3 2021.

Question 4

Is Cresset Asset Management buying or selling MCRB?

Accepted Answer

In Q3 2021, Cresset Asset Management exited its entire MCRB position.

Question 5

When did Cresset Asset Management first buy MCRB?

Accepted Answer

Cresset Asset Management first reported MCRB in its Q2 2020 13F and listed it in 5 quarterly 13F filings.